- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.3390/cells12121603
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2023
- Urheber
-
Gäberlein, Kiara
Schröder, Sarah Katharina
Nanda, Indrajit
Steinlein, Claus
Haaf, Thomas
Buhl, Eva Miriam
Sauvant, Patrick
Sapin, Vincent
Abergel, Armand
Weiskirchen, Ralf
- DOI
-
10.18154/RWTH-CONV-251554
- URN
-
urn:nbn:de:101:1-2023072701333243785024
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gäberlein, Kiara
- Schröder, Sarah Katharina
- Nanda, Indrajit
- Steinlein, Claus
- Haaf, Thomas
- Buhl, Eva Miriam
- Sauvant, Patrick
- Sapin, Vincent
- Abergel, Armand
- Weiskirchen, Ralf
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2023
Ähnliche Objekte (12)
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Established Hepatic Stellate Cell Lines in Hepatology Research
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9
Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Established Hepatic Stellate Cell Lines in Hepatology Research
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9
Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Established Hepatic Stellate Cell Lines in Hepatology Research
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9
Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021